Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab + WBRT for HER-2 Positive Breast Cancer Brain Metastases
NCT01363986Phase 2Terminated
- Sponsor
- Roche
- Start
- Sep 2011
- Primary completion
- Jun 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in breast cancer, sponsored by Roche. Started Sep 2011; status: terminated.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01363986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01363986.